Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
72 studies found for:    eye diseases AND university of iowa
Show Display Options
Rank Status Study
1 Unknown  FaceBase Biorepository
Conditions: Craniofacial Abnormalities;   Cleft Lip;   Cleft Palate
Intervention:
2 Unknown  Corneal Topographer Fluorescein Patterns
Condition: Keratoconus
Intervention: Other: Comparison of fluorescein patterns
3 Unknown  Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface
Conditions: Myopia;   Refractive Error
Interventions: Drug: ReNu MultiPlus® MultiPurpose Solution;   Drug: OPTI-FREE® RepleniSH®;   Drug: Clear Care®
4 No longer available Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate
Condition: Macular Degeneration
Intervention: Drug: Anecortave Acetate
5 Active, not recruiting Teprotumumab Treatment in Patients With Active Thyroid Eye Disease
Conditions: Thyroid Associated Ophthalmopathies;   Thyroid-Associated Ophthalmopathy
Interventions: Drug: teprotumumab;   Drug: Placebo
6 Completed
Has Results
Age-Related Eye Disease Study 2 (AREDS2)
Conditions: Age-related Macular Degeneration;   Cataract
Interventions: Dietary Supplement: Lutein/zeaxanthin;   Dietary Supplement: DHA/EPA;   Drug: Lutein/zeaxanthin and DHA/EPA
7 Unknown  Evaluation of the Bausch & Lomb PureVision Under Nighttime Driving Conditions
Condition: Astigmatism
Intervention:
8 Active, not recruiting Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis
Conditions: Inherited Retinal Dystrophy Due to RPE65 Mutations;   Leber Congenital Amaurosis
Intervention: Biological: AAV2-hRPE65v2
9 Recruiting Retinal Therapy Guided by 3D OCT Image Analysis
Conditions: Age-Related Macular Degeneration;   Choroidal Neovascularization
Intervention:
10 Unknown  Tears Substitutions and Their Effects on Higher Order Aberrometery
Condition: Dry Eye Syndrome
Interventions: Other: Preservative Free Saline;   Other: Optive;   Other: Refresh Moderate/Severe;   Other: Systane;   Other: Systane Ultra
11 Completed
Has Results
Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients
Condition: Allergic Conjunctivitis
Intervention: Drug: Olopatadine hydrochloride ophthalmic solution, 0.2%
12 Suspended Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
Conditions: Acoustic Schwannoma;   Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Meningioma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Stem Glioma;   Adult Choroid Plexus Tumor;   Adult Craniopharyngioma;   Adult Diffuse Astrocytoma;   Adult Ependymoblastoma;   Adult Ependymoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Grade I Meningioma;   Adult Grade II Meningioma;   Adult Medulloblastoma;   Adult Meningeal Hemangiopericytoma;   Adult Mixed Glioma;   Adult Myxopapillary Ependymoma;   Adult Oligodendroglioma;   Adult Papillary Meningioma;   Adult Pilocytic Astrocytoma;   Adult Pineal Gland Astrocytoma;   Adult Pineoblastoma;   Adult Pineocytoma;   Adult Subependymal Giant Cell Astrocytoma;   Adult Subependymoma;   Adult Supratentorial Primitive Neuroectodermal Tumor (PNET);   Childhood Choroid Plexus Tumor;   Childhood Craniopharyngioma;   Childhood Ependymoblastoma;   Childhood Grade I Meningioma;   Childhood Grade II Meningioma;   Childhood Grade III Meningioma;   Childhood High-grade Cerebellar Astrocytoma;   Childhood High-grade Cerebral Astrocytoma;   Childhood Infratentorial Ependymoma;   Childhood Low-grade Cerebellar Astrocytoma;   Childhood Low-grade Cerebral Astrocytoma;   Childhood Medulloepithelioma;   Childhood Supratentorial Ependymoma;   Meningeal Melanocytoma;   Newly Diagnosed Childhood Ependymoma;   Recurrent Adult Brain Tumor;   Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Diffuse Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Fibrillary Astrocytoma;   Recurrent Childhood Gemistocytic Astrocytoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Medulloblastoma;   Recurrent Childhood Oligoastrocytoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Childhood Pilomyxoid Astrocytoma;   Recurrent Childhood Pineoblastoma;   Recurrent Childhood Pleomorphic Xanthoastrocytoma;   Recurrent Childhood Protoplasmic Astrocytoma;   Recurrent Childhood Subependymal Giant Cell Astrocytoma;   Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor;   Recurrent Childhood Visual Pathway and Hypothalamic Glioma;   Recurrent Childhood Visual Pathway Glioma;   Untreated Childhood Anaplastic Astrocytoma;   Untreated Childhood Anaplastic Oligodendroglioma;   Untreated Childhood Brain Stem Glioma;   Untreated Childhood Cerebellar Astrocytoma;   Untreated Childhood Cerebral Astrocytoma;   Untreated Childhood Diffuse Astrocytoma;   Untreated Childhood Fibrillary Astrocytoma;   Untreated Childhood Gemistocytic Astrocytoma;   Untreated Childhood Giant Cell Glioblastoma;   Untreated Childhood Glioblastoma;   Untreated Childhood Gliomatosis Cerebri;   Untreated Childhood Gliosarcoma;   Untreated Childhood Medulloblastoma;   Untreated Childhood Oligoastrocytoma;   Untreated Childhood Oligodendroglioma;   Untreated Childhood Pilocytic Astrocytoma;   Untreated Childhood Pilomyxoid Astrocytoma;   Untreated Childhood Pineoblastoma;   Untreated Childhood Pleomorphic Xanthoastrocytoma;   Untreated Childhood Protoplasmic Astrocytoma;   Untreated Childhood Subependymal Giant Cell Astrocytoma;   Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor;   Untreated Childhood Visual Pathway and Hypothalamic Glioma;   Untreated Childhood Visual Pathway Glioma
Interventions: Radiation: gallium Ga 68-edotreotide;   Procedure: positron emission tomography;   Procedure: computed tomography;   Other: laboratory biomarker analysis
13 Active, not recruiting Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD)
Condition: Age Related Macular Degeneration
Intervention: Drug: 3 dose cohorts gene therapy
14 Active, not recruiting Cornea Preservation Time Study
Conditions: Cornea Preservation Time;   Endothelial Keratoplasty;   Transplant Success;   Endothelial Cell Density
Intervention: Biological: Cornea tissue transplant
15 Terminated A Multi-Center, Randomized, Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery
Conditions: Keratoconus;   Corneal Ectasia
Interventions: Device: KXL System (15 mW/cm2);   Device: KXL System (30 mW/cm2);   Device: KXL System (45 mW/cm2);   Drug: riboflavin ophthalmic solution
16 Completed Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
Condition: Diabetic Retinopathy
Interventions: Procedure: Photography of the retina;   Procedure: Retinal photography
17 Completed Complications of Age-Related Macular Degeneration Prevention Trial
Condition: Macular Degeneration
Intervention: Procedure: Low-Intensity Laser Treatment
18 Active, not recruiting
Has Results
Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial
Condition: Age Related Macular Degeneration
Interventions: Drug: ranibizumab;   Drug: bevacizumab
19 Terminated Inositol to Reduce Retinopathy of Prematurity
Condition: Retinopathy of Prematurity (ROP)
Interventions: Drug: myo-Inositol 5% Injection;   Drug: Placebo
20 Active, not recruiting
Has Results
Surfactant Positive Airway Pressure and Pulse Oximetry Trial
Conditions: Infant, Newborn, Diseases;   Other Preterm Infants;   Infant, Small for Gestational Age;   Premature Birth;   Bronchopulmonary Dysplasia;   Retinopathy of Prematurity
Interventions: Drug: Surfactant;   Device: Continuous Positive Airway Pressure (CPAP);   Drug: Supplemental oxygen with target saturation of 85 to 89%;   Drug: Supplemental oxygen with target saturation of 91 to 95%

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.